Sun Pharmaceutical Industries Ltd share price logo

Sun Pharmaceutical Share Price

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

₹1707.80

+3.20

(+0.19%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sun Pharmaceutical Stock Performance

as on February 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,702.10
    ₹1,719.80
    downward going graph

    0.33%

    Downside

    0.70%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,548.00
    ₹1,851.20
    downward going graph

    9.36%

    Downside

    8.40%

    Upside

    downward going graph

Sun Pharmaceutical share price movements today

Previous Close
₹1,704.60
Open
₹1,709.60
Volume
18.70L
Upper Circuit
₹1,875.00
Lower Circuit
₹1,534.20
Day's Low - High
₹1,702.10 - ₹1,719.80
52 Week Low - High
₹1,548.00 - ₹1,851.20

Sun Pharmaceutical Historical Returns

1 Month Return
-1.62 %
3 Month Return
-0.48 %
1 Year Return
+ 0.47 %
3 Year Return
+ 68.21 %
5 Year Return
+ 165.33 %

Sun Pharmaceutical Fundamentals

as on February 10, 2026 at 4:01 pm IST

Market Cap

₹4,08,990.64 Cr

Return on Equity (ROE)

17.83

PE Ratio (TTM)

37.46

Return on capital employed (ROCE)

16.29

Industry PE ratio

40.65

Beta (LTM)

0.75

P/B Ratio

17.11

Dividend Yield

0.92

PEG Ratio

-17.03

Quarterly Earnings Growth YOY

16.57

EPS (TTM)

45.76

Sector

Pharmaceuticals

Book Value

301

Technical Analysis

Bullish

View Technical Analysis

Sun Pharmaceutical Stock Valuation

as on February 10, 2026 at 4:01 pm IST

Sun Pharmaceutical in the last 5 years

  • Overview

  • Trends

Lowest (19.47x)

March 23, 2020

Today (37.46x)

February 9, 2026

Industry (40.65x)

February 9, 2026

Highest (184.63x)

August 28, 2020

LowHigh

Today’s Price to Earnings Ratio: 37.46x

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharmaceutical Industries Ltd image
Sun Pharmaceutical Industries Ltd
BUY4,08,990.6433.07%0.5210,98052,578
Divis Laboratories Ltd image
Divis Laboratories Ltd
HOLD1,62,294.2212.9%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,35,283.4142.55%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY60,613.85-1.74%0.781,42915,261
Gland Pharma Ltd image
Gland Pharma Ltd
BUY31,053.29-3.49%0.536985,616
See all

Analyst Recommendation on Sun Pharmaceutical Stock

Based on 36 analysts

BUY

88.89%

Buy

0.00%

Hold

11.11%

Sell

Based on 36 analysts, 88.89% of analysts recommend a 'BUY' rating for Sun Pharmaceutical. Average target price of ₹1976.5

Source: S&P Global Market Intelligence

Sun Pharmaceutical Share Price Target

Get share price movements and forecasts by analysts on Sun Pharmaceutical.

What analysts predicted

15.73%UPSIDE

Target Price

₹1976.5

Current Price

₹1707.8

Analyzed by

36 Analysts

High

₹2250

Target

₹1976.50

Low

₹1550

Sun Pharmaceutical target price ₹1976.5, a slight upside of 15.73% compared to current price of ₹1707.8. According to 36 analysts rating.

Source: S&P Global Market Intelligence

Sun Pharmaceutical Stock’s Investor Sentiment and Interest

Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has grown by 67.50% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:67.50% versus previous 30 day period

Search interest for Sun Pharmaceutical Industries Ltd Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:67% versus previous 30 day period

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
10,725.57
11,785.15
12,003.11
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
15,469.07
Other Income
373.28
204.44
293.61
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
578.84
Total Income
11,303.95
12,145.28
12,486.02
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
16,099.38
Expenses
8,299.99
8,931.94
9,013.03
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
11,061.53
Operating Profit
2,425.58
2,853.21
2,990.08
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
4,407.54
Operating Profit Margin %
22.61%
24.21%
24.91%
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
28.49%
Profit Before Interest, Tax and Depreciation
3,003.96
3,213.34
3,472.99
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
5,037.85
Interest
92.74
80.88
49.29
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
78.36
Depreciation
671.53
651.32
632.82
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
732.33
Profit Before Tax
2,239.69
2,481.14
2,790.88
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
4,227.16
Tax Paid
222.91
468.1
390.1
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
826.07
Profit After Tax
2,016.78
2,013.04
2,400.78
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
3,401.09
Total Net profit including share of profit / Loss from associate company
1,982.9
2,005.65
2,385.1
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
3,381.17
EPS
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Actual EPS
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Adjusted EPS
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Diluted EPS
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
30,264.23
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
Other Income
623.15
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
Total Income
32,201.59
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
Expenses
21,489.17
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
Operating Profit
8,775.06
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
Operating Profit Margin %
28.99%
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
Profit Before Interest, Tax and Depreciation
10,712.42
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
Interest
399.8
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
Depreciation
1,264.75
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
Profit Before Tax
9,047.87
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
Tax Paid
1,211.57
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
Profit After Tax
7,836.3
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
Total Net profit including share of profit / Loss from associate company
7,846.23
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Actual EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Adjusted EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Diluted EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12

Sun Pharmaceutical Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
19.24%
19.75%
19.67%
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
20.82%
FII
0%
0%
16.79%
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
16.12%
Public
9.39%
9.29%
9.06%
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
8.58%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,25,252
6,24,561
6,16,588
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877
7,10,900

Mutual Funds that own Sun Pharmaceutical Stock

Check out the Mutual Funds with significant holdings in Sun Pharmaceutical.

Sun Pharmaceutical Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharmaceutical.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 16.03% since last year same period to ₹3,368.81Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 8.05% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Sun Pharmaceutical Industries Ltd Dividends January,2026

    In the quarter ending December 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹11.00 per share on 31 Jan 2026 - translating a dividend yield of 1.58%.

    Read More about Dividends

Indices Featuring Sun Pharmaceutical Stock

Check stock indices that include Sun Pharmaceutical.

Nifty100 Low Volatility 30

₹20,786.75

0.07 (▲14.30%)

S&P BSE 100 ESG

₹433.13

0.22 (▲0.95%)

NIFTY PHARMA

₹22,210.50

-0.36 (▲80.20%)

BSE Healthcare

₹42,603.55

0.07 (▲28.76%)

BSE 100

₹27,165.13

0.23 (▲62.03%)

BSE 500

₹37,207.34

0.25 (▲94.11%)

Nifty 200

₹14,483.45

0.29 (▲41.55%)

Nifty100 Eq Weig

₹34,220.55

0.20 (▲67.15%)

BSE MFG

₹1,111.16

0.64 (▲7.07%)

NIFTY 50

₹25,935.15

0.26 (▲67.85%)

S&P BSE 100 LargeCap TMC

₹9,590.74

0.24 (▲22.79%)

SENSEX

₹84,273.92

0.25 (▲208.17%)

S&P BSE Low Volatility

₹1,875.79

0.12 (▲2.18%)

Nifty Healthcare

₹14,275.00

-0.27 (▲38.95%)

BSE 200

₹11,759.69

0.24 (▲27.78%)

NIFTY 100

₹26,552.10

0.24 (▲64.30%)

S&P BSE SENSEX 50

₹27,087.09

0.26 (▲70.33%)

S&P BSE 250 LargeMidCap

₹11,142.30

0.23 (▲25.92%)

S&P BSE Dividend Stability

₹1,087.80

0.44 (▲4.72%)

Nifty LargeMidcap 250

₹16,843.05

0.32 (▲53.50%)

Nifty 500

₹23,753.75

0.30 (▲70.35%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SUNPHARMA stock has moved up by 0.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.14K Cr → 3.36K Cr (in ₹), with an average increase of 13.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 13.57K Cr → 16.09K Cr (in ₹), with an average increase of 5.5% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.8% return, outperforming this stock by 93.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.2% return, outperforming this stock by 26.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.73% to 8.58% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.41% to 12.09% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.55% to 16.12% in Dec 2025 quarter

Sun Pharmaceutical Stock Futures & Options Contracts

View the latest movement in Sun Pharmaceutical Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharmaceutical Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 24 Feb ₹1700 Call
February 24, 2026
₹1700
₹23.6
-0.65
-2.68%
SUNPHARMA 24 Feb ₹1720 Call
February 24, 2026
₹1720
₹14
-0.75
-5.08%
SUNPHARMA 24 Feb ₹1710 Call
February 24, 2026
₹1710
₹18.5
-0.7
-3.65%
SUNPHARMA 24 Feb ₹1750 Call
February 24, 2026
₹1750
₹6.55
-0.3
-4.38%

Sun Pharmaceutical Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 24 Feb Fut
February 24, 2026
-
₹1708.6
1.54
0.09%
SUNPHARMA 30 Mar Fut
March 30, 2026
-
₹1718
-0.17
-0.01%
SUNPHARMA 28 Apr Fut
April 28, 2026
-
₹1729.3
0.17
0.01%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹15,469.07Cr as on December 2025 (Q3 FY26)
Net Profit: ₹3,401.09Cr as on December 2025 (Q3 FY26)
Listing date: 08 Feb, 1995
Abzorb Share Price
Pepfiz Share Price
Revital Share Price
Volini Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharmaceutical share price today?

Sun Pharmaceutical share price today stands at ₹1707.8 as on at the close of the market. Sun Pharmaceutical share today touched a day high of ₹1719.8 and a low of ₹1702.1.

What is the 52 week high and 52 week low range for Sun Pharmaceutical share?

Sun Pharmaceutical touched a 52 week high of ₹1851.2 and a 52 week low of ₹1548. Sun Pharmaceutical share price today i.e. is closed at ₹1707.8, which is -7.75% down from its 52 week high and 10.32% up from its 52 week low.

What is Sun Pharmaceutical's market capitalisation today?

Sun Pharmaceutical market capitalisation is ₹4,08,990.64 Cr as on .

How to buy Sun Pharmaceutical shares?

To buy Sun Pharmaceutical shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharmaceutical shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharmaceutical trading volume today?

Sun Pharmaceutical trading volume is 18.70L as on . This means that 18.70L shares of Sun Pharmaceutical were bought and sold on the stock market during today's trading session.